Cleared Special

K081450 - RIGHTEST BLOOD GLUCOSE MONITORING SYSTEM, MODEL GM110

K081450 is an FDA 510(k) clearance for RIGHTEST BLOOD GLUCOSE MONITORING SYSTEM, manufactured by Bionime Corporation. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 111-day FDA review.

K081450 · Bionime Corporation · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2008
Decision
111d
Days
Class 2
Risk

K081450 is an FDA 510(k) clearance for the RIGHTEST BLOOD GLUCOSE MONITORING SYSTEM, MODEL GM110. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Bionime Corporation (Great Neck, US). The FDA issued a Cleared decision on September 11, 2008 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K081450

510(k) Number K081450 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 2008
Decision Date September 11, 2008
Days to Decision 111 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d slower than avg
Panel avg: 89d · This submission: 111d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 513
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K081450.
GLUCOFACTS EXPRESS DIABETES MANAGEMENT SOFTWARE
K082486 · Bayer Healthcare, LLC · Oct 2008
ULTRA TRAK PRO BLOOD GLUCOSE MONITORING SYSTEM, MODEL TD-455
K082618 · Taidoc Technology Corporation · Oct 2008
RIGHTEST BLOOD GLUCOSE MONITORING SYSTEM, MODEL GM100
K081451 · Bionime Corporation · Sep 2008
PRECISION XCEED PRO BLOOD GLUCOSE AND B-KETONE MONITORING SYSTEM WITH MODELS BGMS:70900-03, 70090-02, G3CH STRIPS
K080960 · Abbott Diabetes Care, Inc. · Sep 2008
TYSONBIO LINK HEALTH MANAGEMENT SYSTEM
K081726 · Tyson Bioresearch, Inc. · Aug 2008
TRUERESULT BLOOD GLUCOSE SYSTEM E4H01-81
K080641 · Home Diagnostics, Inc. · Aug 2008
K081450 · RIGHTEST BLOOD GLUCOSE MONITORING SYSTEM, MODEL GM110
Download PDF FDA Summary Bionime Corporation